Optometrist Canyon City Eyecare Azusa, California, United States
Disclosure(s): No relevant disclosure to display
Disclosure(s):
Milton M. Hom, OD: No relevant disclosure to display
Is dry eye an autoimmune inflammatory surface disease, or is dry eye an obstruction of the meibomian gland? Both sides sport very different treatment pathways–which is the key to your patient’s success? An understanding of the mucosal immune system is a significant factor. We present both sides of how and when to use anti-inflammatories, mechanical therapies, and devices in your treatment paradigm.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Learn about dry eye classifications
Learn about meibomian gland dysfunction (MGD) and causes
Know the differences between inflammatory and obstructive MGD
Understand the overlap between inflammation and obstruction
Learn about treatment strategies for inflammatory ocular surface disease
Learn about the options for management of obstructive MGD